newsfilter
← Latest News
GlobeNewswire·

Join Biovie's Exclusive Live Investor Webinar and Q&A Session on March 4

CARSON CITY, Nev., Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases,